New: NCI-funded clinical trial search
Mednet Logo
CommunityNeurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

How effective have you found acupuncture for treatment of chronic migraine?

5 Answers

Mednet MemberInvited Expert
Neurology · University of California, Los Angeles

I would prefer to educate a patient interested in acupuncture for severe headaches about all the other treatments that are available. However, if they would still like to pursue acupuncture, I would support them, just like Dr. @Dr. First Last would say. Some patients can get better, although it is n...

How has the utilization of mobile stroke units changed the landscape of in-hospital stroke management?

1 Answers

Mednet MemberInvited Expert
Neurosurgery · Cedars-Sinai Medical Center

Mobile stroke units shift CT-based diagnosis, thrombolysis, and LVO triage into the prehospital setting, enabling earlier hospital activation and direct-to-angiography workflows. In BEST-MSU, onset-to-thrombolysis fell from 108 to 72 minutes, treatment rates rose from 79.5% to 97.1%, and 90-day mRS ...

What are the key factors that you seek to uncover in order to land on the most effective DMT choice for patients with MS?

4 Answers

Mednet MemberInvited Expert
Neurology · Wayne State University School of Medicine

I generally consider three major domains when selecting a DMT: patient-specific factors, clinical disease characteristics, and radiographic disease characteristics. From a disease perspective, I look for clinical and MRI features associated with a higher risk of future disability. For example, signi...

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

Do you add antiplatelet medications to patients already on anticoagulation for atrial fibrillation if they have a stroke due to a competing etiology?

1
3 Answers

Mednet MemberInvited Expert
Neurology · Vanderbilt University Medical Center

Adding antiplatelet therapy to anticoagulation in patients with atrial fibrillation and a noncardioembolic stroke has not shown a clear benefit and definitely increases bleeding risk. Okazaki et al., PMID 41051787 did not find a benefit and increased bleeding risk. An exception might be in acute MI ...

Have you changed your practice in treating CRAO with IV thrombolysis?

5
5 Answers

Mednet MemberInvited Expert
Neurology · University of Virginia School of Medicine

The recent THEIA trial had a limited sample size to draw conclusions, even though there was a non-significant trend of improved visual acuity initially in the thrombolysis group. Even the TenCRAOS trial had a small sample size with recruitment challenges, where subtle small differences cannot be acc...

How to approach reversal of TNK in hemorrhagic conversion of ischemic stroke?

1
2 Answers

Mednet MemberInvited Expert
Neurology · University of Calgary

There is no specific "reversal agent" for tenecteplase. Once administered, the thrombolytic effect will persist until the drug is fully metabolized and any residual plasmin has been cleared by alpha-2-antiplasmin. So, perhaps the first question is what can you do if there is an acute bleeding event ...

Should mRS be incorporated into determining eligibility for extended window thrombolysis?

2 Answers

Mednet MemberInvited Expert
Neurology · University of Virginia School of Medicine

Key thrombolysis trials (WAKE UP, OPTION, EXTEND, TIMELESS, ECASS-4, HOPE, EXTEND IA) excluded patients with mRS of 2 or greater. The reason for this was the outcome of functional independence at 90 days. Hence, for trial purposes, to look at the outcome, it was necessary to exclude patients with di...

How do you decide when to intervene directly on a feeder artery aneurysm of an AVM?

3 Answers

Mednet MemberInvited Expert
Neurosurgery · University at Buffalo

In a ruptured AVM, we treat the feeding artery aneurysm as a priority and emergently. Either surgery or embolization is warranted. I prefer embolization in the hyperacute setting. In unruptured AVMs with a feeding artery aneurysm that have angioarchitecture amenable to catheterization, I prefer to e...

Do you treat migraine with aura if there is not an associated headache/pain?

1
3 Answers

Mednet MemberInvited Expert
Neurology · UPMC

I do if it interferes with quality of life. I do not recommend abortive medications for aura. There is no evidence that migraine abortive treatments shorten the duration of aura. I do not think that they do. Anecdotally, I have had some patients report that taking NSAIDs or a triptan at the aura ons...

How do you navigate C-2 refills in patients who are stable in their treatment and do not otherwise need to be clinically seen monthly?

4
8 Answers

Mednet Member
Psychiatry

This practice is routine in child psychiatry. We fill stimulant prescriptions electronically at the phone request of the family as long as they are keeping quarterly appointments. We do not charge for that service. We do document it in the medical record. Your question begs another question, however...